Quality of life and quality-adjusted survival (Q-TWiST) in patients receiving dose-intensive or standard dose chemotherapy for high-risk primary breast cancer

Quality of life (QL) is an important consideration when comparing adjuvant therapies for early breast cancer, especially if they differ substantially in toxicity. We evaluated QL and Q-TWiST among patients randomised to adjuvant dose-intensive epirubicin and cyclophosphamide administered with filgra...

Descripción completa

Detalles Bibliográficos
Autores principales: Bernhard, J, Zahrieh, D, Zhang, J J, Martinelli, G, Basser, R, Hürny, C, Forbes, J F, Aebi, S, Yeo, W, Thürlimann, B, Green, M D, Colleoni, M, Gelber, R D, Castiglione-Gertsch, M, Price, K N, Goldhirsch, A, Coates, A S
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2008
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2359705/
https://www.ncbi.nlm.nih.gov/pubmed/18043579
http://dx.doi.org/10.1038/sj.bjc.6604092

Ejemplares similares

Ejemplares similares